HealthMap

Betamethasone Prenatal Injection and Fetal Lung Maturity

Overview

• Standard Medical Application: Betamethasone is a corticosteroid routinely administered to pregnant women at risk of preterm delivery (typically between 24 and 34 weeks of gestation).
• Primary Purpose: Its main physiological effect is to accelerate fetal lung maturation by stimulating the production of surfactant, a substance critical for normal lung expansion and function after birth.

Key Benefits

• Reduced Respiratory Distress: Significantly lowers the incidence and severity of Respiratory Distress Syndrome (RDS) in premature infants.
• Improved Survival: Associated with lower overall rates of neonatal mortality, intracranial hemorrhage, and necrotizing enterocolitis.

Nutritional and Biochemical Considerations

• Enzyme and Nutrient Utilization: Corticosteroids alter maternal and fetal metabolic pathways, increasing demands on specific micronutrients involved in tissue synthesis and cellular repair.
• Immune and Antioxidant Status: High pharmacological doses of steroids can temporarily impact immune function and deplete certain cellular reserves, emphasizing the importance of adequate nutritional status during high-risk pregnancies.